Dikhyaa Mohanty 
Pfizer will seek US authorisation for a third dose of its COVID-19 vaccine, and that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.
According to the official reports, the research from various countries shows that Pfizer shot and other widely used COVID-19 vaccines offer strong protection against the highly contagious delta variant, which is spreading rapidly around the world and now accounts for most new U.S. infections.
Two doses of most vaccines are critical to developing high levels of virus-fighting antibodies against all versions of the coronavirus, not just the delta variant and most of the world still is desperate to get those initial protective doses as the pandemic continues to rage.
The report further added that antibodies naturally wane over time, so studies also are underway to tell if and when boosters might be needed.
Pfizer’s Dr Mikael Dolsten stated that early data from the company’s booster study suggests people’s antibody levels jump five- to 10-fold after a third dose, compared to their second dose months earlier.
Image Source – Google
